Mergers & Acquisitions

The firm has a substantial track-record in representation of purchasers and targets in private and public merger and acquisition transactions, and is widely experienced in private and public mergers includes the involvement and advice in reverse mergers, mergers into publicly traded shells, asset purchases and share acquisitions. Some recent examples are the representation of cCam Biotherapeutics Ltd. in its sale to Merck & Co. Inc., Cellera Technologies, Inc. in its asset sale to Elron, and Babylon Software Ltd. in the purchase of assets of Babylon Ltd.

Further examples of such representation include:
o V-gen shareholders in the acquisition by NewPort (2014)
o VIM shareholders in the acquisition by Presstek, Inc. (2013)
o Reverse triangular merger of Immune into Epicept Corp.(2012)
o Sale of ILS Brokers Ltd. to Leader Capital Markets Ltd..(2012)
o Sale of Picapp, Inc. to Ybrant (2011)
o Collplant in its merger with Portfolio Green Ltd. (TASE) (June 2010);
o Large US developer and distributor of medical devices in the purchase of Israeli technology (July 2010);
o Israeli company in its purchase of an Israeli developer of medical devices;
o Selling shareholder in the sale of Ventor Technologies Ltd. with Medtronic Inc. (February 2009);
o Dblur Technologies Ltd. In its sale of assets to Tessera, Inc. (May, 2009);
o Reverse triangular merger of Protalix Ltd. into Orthodontix, Inc. (Protalix Biotehapeutics, Inc (AMEX; PLX). (2006)